Foundry Partners has released a thought leadership paper titled “The Pharma/Biotech Dilemma: How current Small and Microcap Index weightings in the pharma and biotech industries are creating a dilemma for traditional value managers.” The paper was authored by Mark Roach and Mario Tufano (CFA) with the intent of demonstrating the dilemma that the pharma/biotech weightings within the Russell Small Cap & Microcap Value indices are creating for value managers. We encourage you to download the full version and contact us if you have any questions.
To download the paper, please click on the image below:
